Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -127,363 | -76,838 | -31,934 | -101,944 | -71,450 |
| Depreciation Amortization | 1,563 | 794 | 377 | 1,168 | 720 |
| Accounts receivable | -290 | -657 | -234 | -14 | -26 |
| Accounts payable and accrued liabilities | 9,108 | 2,995 | -2,770 | 76 | -4,637 |
| Other Working Capital | 6,936 | -916 | -3,471 | 402 | -4,804 |
| Other Operating Activity | -1,303 | 4,892 | 6,419 | 11,461 | 12,915 |
| Operating Cash Flow | $-111,349 | $-69,730 | $-31,613 | $-88,851 | $-67,282 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -101,371 | -62,128 | 12,341 | -69,752 | -95,172 |
| PPE Investments | -470 | -387 | -248 | -1,326 | -80 |
| Investing Cash Flow | $-101,841 | $-62,515 | $12,093 | $-71,078 | $-95,252 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 49,962 | 49,961 | N/A | 48,868 | 23,899 |
| Common Stock Issued | 138,823 | 139,034 | N/A | 94,205 | 94,268 |
| Common Stock Repurchased | -824 | -824 | -824 | -864 | -864 |
| Financing Cash Flow | $187,961 | $188,171 | $-824 | $142,209 | $117,303 |
| Beginning Cash Position | 46,345 | 46,345 | 46,345 | 64,065 | 64,065 |
| End Cash Position | 21,116 | 102,271 | 26,001 | 46,345 | 18,834 |
| Net Cash Flow | $-25,229 | $55,926 | $-20,344 | $-17,720 | $-45,231 |
| Free Cash Flow | |||||
| Operating Cash Flow | -111,349 | -69,730 | -31,613 | -88,851 | -67,282 |
| Capital Expenditure | -470 | -387 | -248 | -1,326 | -80 |
| Free Cash Flow | -111,819 | -70,117 | -31,861 | -90,177 | -67,362 |